471 related articles for article (PubMed ID: 16024189)
1. Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process.
Won DH; Kim MS; Lee S; Park JS; Hwang SJ
Int J Pharm; 2005 Sep; 301(1-2):199-208. PubMed ID: 16024189
[TBL] [Abstract][Full Text] [Related]
2. Alternative solvent-free preparation methods for felodipine surface solid dispersions.
Kerc J; Srcic S; Kofler B
Drug Dev Ind Pharm; 1998 Apr; 24(4):359-63. PubMed ID: 9876596
[TBL] [Abstract][Full Text] [Related]
3. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
4. Preparation of a solid dispersion of felodipine using a solvent wetting method.
Kim EJ; Chun MK; Jang JS; Lee IH; Lee KR; Choi HK
Eur J Pharm Biopharm; 2006 Oct; 64(2):200-5. PubMed ID: 16750355
[TBL] [Abstract][Full Text] [Related]
5. [Study on the properties of felodipine solid dispersions prepared by different technologies].
Shi NQ; Zhang H; Zhang Y; Feng B; Li ZQ; Qi XR
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1067-1073. PubMed ID: 27987515
[TBL] [Abstract][Full Text] [Related]
6. Screen for Inhibitors of Crystal Growth to Identify Desirable Carriers for Amorphous Solid Dispersions Containing Felodipine.
Fu J; Cui L; Yang C; Xiong H; Ren G; Ma X; Jing Q; Ren F
AAPS PharmSciTech; 2018 Apr; 19(3):1231-1242. PubMed ID: 29302871
[TBL] [Abstract][Full Text] [Related]
7. Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods.
Li Y; Yang DJ; Chen SL; Chen SB; Chan AS
Pharm Res; 2008 Mar; 25(3):563-77. PubMed ID: 17828444
[TBL] [Abstract][Full Text] [Related]
8. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.
Djuris J; Milovanovic S; Medarevic D; Dobricic V; Dapčević A; Ibric S
Int J Pharm; 2019 Jan; 554():190-200. PubMed ID: 30414899
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.
Karavas E; Georgarakis E; Sigalas MP; Avgoustakis K; Bikiaris D
Eur J Pharm Biopharm; 2007 Jun; 66(3):334-47. PubMed ID: 17267194
[TBL] [Abstract][Full Text] [Related]
10. Preparation and pharmaceutical characterization of amorphous cefdinir using spray-drying and SAS-process.
Park J; Park HJ; Cho W; Cha KH; Kang YS; Hwang SJ
Int J Pharm; 2010 Aug; 396(1-2):239-45. PubMed ID: 20599602
[TBL] [Abstract][Full Text] [Related]
11. Miscibility behavior and formation mechanism of stabilized felodipine-polyvinylpyrrolidone amorphous solid dispersions.
Karavas E; Ktistis G; Xenakis A; Georgarakis E
Drug Dev Ind Pharm; 2005 Jul; 31(6):473-89. PubMed ID: 16109621
[TBL] [Abstract][Full Text] [Related]
12. Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process.
Ha ES; Kim JS; Baek IH; Yoo JW; Jung Y; Moon HR; Kim MS
Drug Des Devel Ther; 2015; 9():4269-77. PubMed ID: 26345723
[TBL] [Abstract][Full Text] [Related]
13. Combining SEM, TEM, and micro-Raman techniques to differentiate between the amorphous molecular level dispersions and nanodispersions of a poorly water-soluble drug within a polymer matrix.
Karavas E; Georgarakis M; Docoslis A; Bikiaris D
Int J Pharm; 2007 Aug; 340(1-2):76-83. PubMed ID: 17478064
[TBL] [Abstract][Full Text] [Related]
14. Effect of poloxamer on the dissolution of felodipine and preparation of controlled release matrix tablets containing felodipine.
Lee KR; Kim EJ; Seo SW; Choi HK
Arch Pharm Res; 2008 Aug; 31(8):1023-8. PubMed ID: 18787792
[TBL] [Abstract][Full Text] [Related]
15. Effects of Polymers on the Drug Solubility and Dissolution Enhancement of Poorly Water-Soluble Rivaroxaban.
Choi MJ; Woo MR; Choi HG; Jin SG
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012748
[TBL] [Abstract][Full Text] [Related]
16. Extensive Diminution of Particle Size and Amorphization of a Crystalline Drug Attained by Eminent Technology of Solid Dispersion: A Comparative Study.
Singh G; Sharma S; Gupta GD
AAPS PharmSciTech; 2017 Jul; 18(5):1770-1784. PubMed ID: 27766512
[TBL] [Abstract][Full Text] [Related]
17. Real time Raman imaging to understand dissolution performance of amorphous solid dispersions.
Tres F; Treacher K; Booth J; Hughes LP; Wren SA; Aylott JW; Burley JC
J Control Release; 2014 Aug; 188():53-60. PubMed ID: 24910191
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.
Mahmah O; Tabbakh R; Kelly A; Paradkar A
J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426
[TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process.
Kim MS; Jin SJ; Kim JS; Park HJ; Song HS; Neubert RH; Hwang SJ
Eur J Pharm Biopharm; 2008 Jun; 69(2):454-65. PubMed ID: 18359211
[TBL] [Abstract][Full Text] [Related]
20. Dissolution and precipitation behavior of amorphous solid dispersions.
Alonzo DE; Gao Y; Zhou D; Mo H; Zhang GGZ; Taylor LS
J Pharm Sci; 2011 Aug; 100(8):3316-3331. PubMed ID: 21607951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
